Your browser doesn't support javascript.
loading
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
Eckstein, Olive S; Allen, Carl E; Williams, P Mickey; Roy-Chowdhuri, Sinchita; Patton, David R; Coffey, Brent; Reid, Joel M; Piao, Jin; Saguilig, Lauren; Alonzo, Todd A; Berg, Stacey L; Ramirez, Nilsa C; Jaju, Alok; Mhlanga, Joyce; Fox, Elizabeth; Hawkins, Douglas S; Mooney, Margaret M; Takebe, Naoko; Tricoli, James V; Janeway, Katherine A; Seibel, Nita L; Parsons, D Williams.
Afiliação
  • Eckstein OS; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.
  • Allen CE; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.
  • Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.
  • Reid JM; Mayo Clinic, Rochester, MN.
  • Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA.
  • Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.
  • Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH.
  • Jaju A; Ann and Robert H. Lurie Children's Hospital, Chicago, IL.
  • Mhlanga J; Washington University School of Medicine, St Louis, MO.
  • Fox E; St Jude Children's Research Hospital, Memphis, TN.
  • Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA.
  • Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.
  • Takebe N; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Seibel NL; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.
  • Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.
J Clin Oncol ; 40(20): 2235-2245, 2022 07 10.
Article em En | MEDLINE | ID: mdl-35363510
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Glioma Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Benzimidazóis / Glioma Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article